| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/27/2009 | EP1525219B1 Glp-1 and methods for treating diabetes |
| 05/27/2009 | EP1366075B1 New interferon beta-like molecules |
| 05/27/2009 | EP1292678B1 G-protein coupled receptors |
| 05/27/2009 | EP1200476B1 Antitumor antibodies, proteins, and uses thereof |
| 05/27/2009 | EP1132402B1 Peptide fragments having cell death inhibitory activity |
| 05/27/2009 | EP1037651B1 Small peptides and methods for treatment of asthma and inflammation |
| 05/27/2009 | EP1003850B1 Inhibitors of dna immunostimulatory sequence activity |
| 05/27/2009 | EP0959899B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 05/27/2009 | EP0939796B1 Uses of oncofetal antigen specific cd4, cd8 cytotoxic and suppressor t cells and interleukin-10 |
| 05/27/2009 | EP0871487B1 Dendritic cell stimulatory factor |
| 05/27/2009 | EP0832228B1 Modified hemoglobin-like compounds and methods of purifying same |
| 05/27/2009 | CN101443454A Polysaccharide-protein latticeing substance and vaccine derivatized from polyvalent meningitis cocci |
| 05/27/2009 | CN101443358A Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation |
| 05/27/2009 | CN101443357A MCP1 fusions |
| 05/27/2009 | CN101443351A Modified molecules which promote hematopoiesis |
| 05/27/2009 | CN101443350A Macrocyclic compounds as antiviral agents |
| 05/27/2009 | CN101443348A Compounds and compositions as channel activating protease inhibitors |
| 05/27/2009 | CN101443080A Use of peptides for the control of radiation injury |
| 05/27/2009 | CN101443047A Inhibition of Li expression in mammalian cells |
| 05/27/2009 | CN101443033A Device for enhancing tissue glucose processing |
| 05/27/2009 | CN101443032A Regulation of immune responses by modulation of the function of antigen presenting cells |
| 05/27/2009 | CN101443031A New application of treatment peptides |
| 05/27/2009 | CN101443030A Use of gelsolin to diagnose and treat inflammatory diseases |
| 05/27/2009 | CN101443029A Intraventricular protein delivery for amyotrophic lateral sclerosis |
| 05/27/2009 | CN101443028A Compositions for delivering peptide YY and PYY agonists |
| 05/27/2009 | CN101443022A Use of a growth-stimulating protein |
| 05/27/2009 | CN101443001A Method of treatment or prophylaxis inflammatory pain |
| 05/27/2009 | CN101440126A Acquisition and use of homing polypeptide with targeting specificity related to tumor and metastases thereof |
| 05/27/2009 | CN101440124A Methods for preventing mitochondrial permeability transition |
| 05/27/2009 | CN101439189A Use of zebra fish Caspy2 gene in preparing medicament for treating tumor |
| 05/27/2009 | CN101439181A Stable water injection medicament composition containing Ulinastatin |
| 05/27/2009 | CN101439180A Medicament composition for improving stability of Ulinastatin |
| 05/27/2009 | CN101439047A Technological process for improving stable FVII yield of human prothrombin complexes |
| 05/27/2009 | CN101439015A Pharmaceutical composition with enhanced bioavailability |
| 05/27/2009 | CN100491532C Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 05/27/2009 | CN100491399C Hybrid protein of p53 protein epitope and filobactivirus gene 8 protein and application thereof |
| 05/27/2009 | CN100491396C Selective cyclic peptides |
| 05/27/2009 | CN100491394C Anti-angiogenic polypeptides |
| 05/27/2009 | CN100491348C Thrombosis resisting preparation |
| 05/27/2009 | CN100490902C Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 05/27/2009 | CN100490896C Chewing tablet for discharging lead, and preparation method |
| 05/27/2009 | CN100490895C CD40-binding APC-activating molecules |
| 05/27/2009 | CN100490893C Osteogenic composition |
| 05/27/2009 | CN100490892C Method for inducing onset of reproductive cycle of female breeding animals |
| 05/27/2009 | CN100490784C Method for preparing protein or polypeptide medicine slow-releasing microball |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538207 Polyepitope carrier protein |
| 05/26/2009 | US7538205 Regulation of human prostasin-like serine protease |
| 05/26/2009 | US7538197 Use of neuregulin-β as an indicator and/or target |
| 05/26/2009 | US7538193 Using deoxy-S-nitrosohemoglobin and glutathione, cysteine and/or N-acetylcysteine to treat and prevent ischemic injury, hypertension, angina, reperfusion injury and inflammation |
| 05/26/2009 | US7538189 Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical and isotopic substitution |
| 05/26/2009 | US7538188 Method for fabricating an olfactory receptor-based biosensor |
| 05/26/2009 | US7538185 Treating a disease or condition associated with a disorder of glucose metabolism; diabetes mellitus of Type I or Type II, insulin resistance |
| 05/26/2009 | US7538183 HPV vaccine comprising peptides from host cell proteins |
| 05/26/2009 | US7538182 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer |
| 05/26/2009 | US7538095 Genetic inhibition by double-stranded RNA |
| 05/26/2009 | US7538093 Compositions and methods for therapeutic use |
| 05/26/2009 | US7538091 D-retro-inverso amino acid sequence transporter peptide conjugated to nucleic acid biological effector; translocation across the membrane of pancreatic B-cells |
| 05/26/2009 | US7538090 Peptide sequence, beta sheet, lipid moiety; a kit with additional drugs, hormones, and vaccines; biomolecule; improves lung compliance by improving absorption that lowers surface tension at air-fluid interface |
| 05/26/2009 | US7538089 Anti-inflammatory compounds and uses thereof |
| 05/26/2009 | US7538088 Method for inhibiting angiogenesis by administration of the extracellular domain of D1-1 polypeptide |
| 05/26/2009 | US7538087 Agent against periodontal disease |
| 05/26/2009 | US7538086 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders |
| 05/26/2009 | US7538085 Macrocyclic peptide antibiotics; drug resistant, drug sensitive bacterial infections |
| 05/26/2009 | US7538084 Cyclosporins |
| 05/26/2009 | US7538083 Compositions and methods for the potentiation of immune responses against target antigens |
| 05/26/2009 | US7538082 Methods and compositions for treating or preventing lesions of the upper alimentary canal, particularly oral aphthous or mucositis lesions. Trefoil peptides are administered in effective concentrations either alone or in combination with |
| 05/26/2009 | US7538071 Methods of reducing the nicotine content of tobacco plants and tobacco plants obtained thereby |
| 05/26/2009 | US7537929 Nucleotide sequences coding serine protease inhibitor for use in targeting and killing insect cell |
| 05/26/2009 | US7537924 Modified herpes simplex viral particle for targeting and destroying tumor cells |
| 05/26/2009 | US7537923 Phenylalanine ammonia-lyase foruse in target destruction of cancer cells |
| 05/26/2009 | US7537922 Residual protease II (RP-II) for enhancing wash performance of detergents |
| 05/26/2009 | US7537919 Cytochrome P450RAI-2 and related proteins |
| 05/26/2009 | US7537908 Using concentration of high mobility group 1 (HMG1) protein as evaluative tool in detection of infection and acute respiratory distress syndrome; treating obesity with high mobility group antagonist |
| 05/26/2009 | US7537899 Defects in periaxin associated with myelinopathies |
| 05/26/2009 | US7537891 Using glyceraldehyde-3-phosphate dehydrogenase expression as evaluative tool in identifying tumor antigen expression; diagnosing and prognosing cell proliferative disorders |
| 05/26/2009 | US7537887 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
| 05/26/2009 | US7537795 Agent is dissolved in water to form aqueous coating solution for coating extremely tiny skin piercing elements, solution is applied to skin piercing elements, dried, device is applied to skin of a living animal causing microprotrusions to pierce stratum corneum and deliver drug |
| 05/26/2009 | US7537786 Complex of drug-carbon nanohorn and a process for producing the complex |
| 05/26/2009 | US7537772 Chlamydia protein, gene sequence and the uses thereof |
| 05/26/2009 | US7537771 Produces an immune response which is protective against Bacillus anthracis |
| 05/26/2009 | US7537769 Webbed immunogens comprising recombinant human immunodeficiency virus (HIV) envelope glycoproteins and the M9 scorpion toxin |
| 05/26/2009 | US7537765 Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 05/26/2009 | US7537760 Monoclonal antibodies recognizing BAG3 protein sequences and their use in diagnostic and therapy of cell death-involving diseases |
| 05/26/2009 | US7537759 Modulating angiogenesis |
| 05/26/2009 | US7537758 Antibodies against a peptide epitope of apolipoprotein B |
| 05/26/2009 | US7537757 Administering an antibody that specifically binds to EMAP(endothelial monocyte-activating polypeptides II) to the subject which needs inhibition of EMAP activity in an amount effective to stimulate vascular growth in cardiac muscle |
| 05/26/2009 | US7537756 Using nestin-positive pancreatic stem cell to generate insulin producing beta cells; tissue engineering and repair; regenerative medicine |
| 05/26/2009 | US7537755 Interferon-alpha polypeptides and conjugates |
| 05/26/2009 | US7537752 Mixture of chelate compound and active material in vehicle |
| 05/26/2009 | CA2497857C Novel p-selectin ligand protein |
| 05/26/2009 | CA2441441C Combination of a taxane and a cyclin-dependent kinase inhibitor |
| 05/26/2009 | CA2440578C Oral peptide pharmaceutical dosage form and method of production |
| 05/26/2009 | CA2411754C 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents |
| 05/26/2009 | CA2403630C Methods for inhibiting angiogenesis and tumor growth |
| 05/26/2009 | CA2334773C Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 05/26/2009 | CA2295936C Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 05/26/2009 | CA2295247C Compositions containing thrombin and microfibrillar collagen |
| 05/26/2009 | CA2254420C Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 05/26/2009 | CA2230492C Human growth hormone variants |